KI-Beratung Beta

Produktbild: Pediatric Neurology, Part I
Band 111

Pediatric Neurology, Part I Volume 111

206,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

21.05.2013

Herausgeber

Olivier Dulac + weitere

Verlag

Elsevier Science & Technology

Seitenzahl

892

Maße (L/B/H)

26,9/19,5/5 cm

Gewicht

2693 g

Auflage

3rd edition

Sprache

Englisch

ISBN

978-0-444-52891-9

Beschreibung

Rezension

"Dulac.and coeditors Lassonde and Sarnat present the first in three volumes on pediatric neurology aimed at clinicians and neuroscientists, which was excluded from previous volumes in the series. It consists of 84 chapters by an international group of neurologists, neuroscientists, pediatricians, and others, on normal psychomotor development, neurological examination, diagnosis, health outcomes measurement, coma and brain death, heredodegenerative disorders,." --Reference & Research Book News, December 2013

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

21.05.2013

Herausgeber

Verlag

Elsevier Science & Technology

Seitenzahl

892

Maße (L/B/H)

26,9/19,5/5 cm

Gewicht

2693 g

Auflage

3rd edition

Sprache

Englisch

ISBN

978-0-444-52891-9

EU-Ansprechpartner

Elsevier B.V.
Radarweg 29
1043 NX Amsterdam
NL
productsafety@elsevier.com

Herstelleradresse

Elsevier Science & Technology
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Pediatric Neurology, Part I
  • SECTION 1 GENERAL INTRODUCTION; Normal psychomotor development; Clinical neurological examination of infants and children; Pediatric neurology - the diagnostic process; Health outcomes measurement: concepts, guidelines and opportunities; Coma; Clinical and imaging diagnosis for heredodegenerative diseases; Developmental aspects of normal EEG; Clinical neurophysiology in movement disorders; Announcing the diagnosis: counselling the parents; Chronic paediatric diseases into adulthood and the challenge of adolescence; Ethical considerations in pediatric neurology; SECTION 2 TOXIC AND DEFICIENCY, FETOPATHIES; Neuroembryology and brain malformations: an overview; Microcephaly; Prenatal-onset neurodevelopmental disorders secondary to toxins, nutritional deficiencies and maternal illness; SECTION 3 CEREBRAL PALSY; Epidemiology of cerebral palsy; Pathophysiology of cerebral palsy; Imaging cerebral palsy; Cerebral palsy: definition, assessment and rehabilitation; Treatment of movement disorders in dystonia-choreoathtosis cerebral palsy; Everyday life and social consequences of cerebral palsy; SECTION 4 DEVELOPMENTAL ABNORMALITIES AND MENTAL RETARDATION; Developmental abnormalities and mental retardation: diagnostic strategy; Specific language impairment; Dyslexia; Congenital Amusia; Developmental dyscalculia; Nonverbal learning disability; Memory disorders in children; Attention deficit; The autistic spectrum; Cognitive and medical features of chromosomal neuploidy; Genetically determined encephalopathy: Rett syndrome; Angelman syndrome; Developmental and cognitive troubles in Williams Syndrome; Smith Magenis syndrome; X-linked mental deficiency; SECTION 5 NEUROECTODERMOSES; Genetics of neural crest and neurocutaneous syndromes; Sturge-Weber syndrome; Tuberous sclerosis; Neurofibromatosis; Incontinentia pigmenti and hypomelanosis of Ito; Epidermal nevus syndrome; Neurocutaneous melanocytosis; SECTION 6 EPILEPSY; The epidemiology of seizure disorders in infancy and childhood: definitions and Classifications; Neuropathology of paediatric epilepsy; The developing cortex; Epileptogenesis in the developing brain; Brain maturation and epilepsy; Modes of onset of epilepsy and differential diagnosis; Varying seizure semiology according to age; Magnetoencephalography (MEG) and other neurophysiological investigations; Neonatal seizures; Febrile and other occasional seizures; Focal epileptogenic lesions; Rasmussen's encephalitis; Immune-mediated paediatric epilepsies; Inborn errors of metabolism and epilepsy; Chromosome disorders associated with epilepsy; Focal malformations of cortical development: a most relevant etiology of epilepsy in Children; Genetics of idiopathic epilepsies; Idiopathic generalized epilepsies; Idiopathic focal epilepsies; Malignant migrating partial seizures in infancy; Infantile spasms; The epileptic encephalopathies; Dravet syndrome (severe myoclonic epilepsy in infancy); Epileptic encephalopathy with continuous spike-waves during slow-wave sleep including Landau-Kleffner syndrome; Lennox-Gastaut syndrome and epilepsy with myoclonic-astatic seizures; Diffuse malformations of cortical development; Myoclonus and epilepsy; Status epilepticus; Cognitive disorders in paediatric epilepsy; Problematic behaviour in children with epilepsy: issues and management; Cognitive side-effects of antiepileptic drugs in children; Initiating antiepileptic drug treatment and characteristics of drugs; Treatment strategies; Developing antiepileptic drugs in children: balancing protection and access; Structural imaging in children with chronic focal epilepsy: exploration strategies and diagnostic algorithms; SPECT (Single photon emission computed tomography) in paediatrics; Functional imaging: PET; Advanced structural and functional MRI in childhood epilepsies; Paediatric epilepsy surgery; Cognitive outcome of surgery; Nonpharmacologic approaches: diet and neurostimulation; Outcome of paediatric epilepsies in adulthood